16 completed, 2 recruiting, 2 terminated, 1 active not recruiting. 9 Phase 3, 7 Not applicable, 3 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 6, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1 |
| Not applicable | 7 | Completed 6, Terminated 1 |
| Phase 4 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Epilepsy, Tonic-Clonic: new trials by email Literature Review of Epilepsy, Tonic-Clonic trials Research Report on Epilepsy, Tonic-Clonic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome Levetiracetam 500mg, Placebo - Down Syndrome, Down Syndrome (DS) | Phase 3 | Recruiting | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 120 | 2025-12-22 | 2026-01-12 |
| Clinical Trial of Vormatrigine in Adult Patients With Epilepsy vormatrogine - Epilepsy, Tonic-Clonic, Focal Seizure | Phase 3 | Enrolling by invitation | Praxis Precision Medicines | 700 | 2025-10-27 | 2026-08-03 |
| A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures Oral Zonisamide Therapy - Epilepsies, Partial, Epilepsy, Tonic-Clonic | Phase 4 | Recruiting | Affiliated Hospital of Nantong University | 30 | 2024-08-01 | 2025-05-13 |
| RNS System NAUTILUS Study Responsive stimulation, Sham stimulation - Epilepsy, Idiopathic Generalized Epilepsy | Not applicable | Completed | NeuroPace | 100 | 2022-08-09 | 2026-06-08 |
| A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder. Fenfluramine, Placebo - CDKL5 Deficiency Disorder, Generalized Tonic Clonic Seizure | Phase 3 | Active not recruiting | Zogenix, Inc. | 87 | 2022-03-08 | 2026-04-29 |
| Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy STARSTIM device, Sham Device - Refractory Epilepsy, Focal Seizure | Not applicable | Completed | Neuroelectrics Corporation | 127 | 2021-10-25 | 2026-04-08 |
| EpiWatch: Evaluation of a Non-EEG Physiological Signal Based Seizure Monitoring System Physiological signal monitoring and seizure detection - Epilepsy, Tonic-Clonic | Not applicable | Completed | EpiWatch, Inc. | 242 | 2021-09-20 | 2025-02-04 |
| A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy Perampanel - Idiopathic Generalized Epilepsy, Partial Onset Seizures | Completed | Eisai Limited | 191 | 2020-07-20 | 2023-02-09 | |
| XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU) Accelerometer Live-Streaming Tool - Epilepsy, Tonic-Clonic | Withdrawn | LivaNova | 2020-03-16 | 2020-08-25 | ||
| Embrace and Quality of Life Embrace with Alert and Mate apps, Embrace with Mate app only - Epilepsy, Tonic-Clonic | Not applicable | Terminated | Centre Hospitalier Universitaire Vaudois | 26 | 2018-10-10 | 2022-07-22 |
| Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study Microburst Stimulation - Epilepsies, Partial, Epilepsy, Tonic-Clonic | Not applicable | Completed | LivaNova | 33 | 2018-02-27 | 2022-10-25 |
| Novel Helmet Design in Patients With Seizures Hövding inflatable helmet - Drug Resistant Epilepsy, Drop Seizures | Not applicable | Completed | Michael A. Gelfand, MD, PhD | 9 | 2017-08-14 | 2025-01-09 |
| Topiramate Bioequivalence Study Brazil - Fast Topiramate coated tablet, Topamax® coated tablet - Epilepsy, Tonic-Clonic | Phase 1 | Completed | GlaxoSmithKline | 26 | 2011-07-22 | 2017-06-28 |
| Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy T-VNS® Stimulator cM02 (Transcutaneous Stimulation of the Vagus Nerve) - Epilepsy | Not applicable | Completed | cerbomed GmbH | 7 | 2009-08-01 | 2011-03-08 |
| IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures Keppra, Fosphenytoin, Dilantin - Tonic-clonic Seizure | Phase 4 | Completed | Emory University | 158 | 2007-07-01 | 2013-12-12 |
| Monotherapy With Levetiracetam in Patients Suffering From Epilepsy. Levetiracetam - Epilepsy, Tonic-clonic | Phase 3 | Completed | UCB Pharma SA | 66 | 2005-08-10 | 2018-11-21 |
| Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures lamotrigine (LAMICTAL) extended-release, Placebo - Epilepsy, Tonic-Clonic | Phase 3 | Completed | GlaxoSmithKline | 153 | 2004-12-01 | 2017-01-02 |
| Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy. LEVETIRACETAM - Epilepsy, Tonic-clonic | Phase 3 | Completed | UCB Pharma | 250 | 2003-07-01 | 2013-11-26 |
| Evaluation and Treatment of Patients With Epilepsy Epilepsy | Terminated | National Institute of Neurological Disorders and Stroke (NINDS) | 1278 | 2001-05-01 | 2019-12-12 | |
| Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug lamotrigine - Epilepsy, Tonic-Clonic | Phase 4 | Completed | GlaxoSmithKline | 141 | 2000-12-01 | 2017-04-04 |
Showing 20 of 23. Sign in to see all of them.
Epilepsy (15) · Seizures (15) · Epilepsies, Partial (3) · Drug Resistant Epilepsy (2) · Epilepsy, Idiopathic Generalized (2) · Alzheimer Disease (1) · CDKL5 deficiency disorder (1) · Dementia (1) · Down Syndrome (1) · Emergencies (1) · Epilepsy, Absence (1) · Epilepsy, Frontal Lobe (1) · Epilepsy, Generalized (1) · Epilepsy, Temporal Lobe (1)
Brain Diseases (23) · Central Nervous System Diseases (23) · Nervous System Diseases (23) · Epilepsy, Generalized (22) · Neurologic Manifestations (15) · Pathological Conditions, Signs and Symptoms (15) · Signs and Symptoms (15) · Epilepsy (8) · Epileptic Syndromes (3) · Neurobehavioral Manifestations (2) · Abnormalities, Multiple (1) · Chromosome Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Consciousness Disorders (1)
Levetiracetam (4) · Topiramate (3) · Lamotrigine (2) · Fenfluramine (1) · Phenytoin (1) · fosphenytoin (1) · perampanel (1)
GlaxoSmithKline (3) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (3) · LivaNova (2) · Affiliated Hospital of Nantong University (1) · Centre Hospitalier Universitaire Vaudois (1) · Eisai Limited (1) · Emory University (1) · EpiWatch, Inc. (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · Michael A. Gelfand, MD, PhD (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · NeuroPace (1) · Neuroelectrics Corporation (1) · Praxis Precision Medicines (1) · UCB Pharma (1)
United States (11) · Germany (5) · Spain (5) · Belgium (4) · Brazil (3) · Italy (3) · Argentina (2) · Chile (2) · France (2) · Poland (2) · Portugal (2) · Russia (2) · Austria (1) · China (1) · Czechia (1)
Debra Houry, MD (1) · Gregory L Krauss, MD (1) · Krisl Vonck (1) · Martha Morrell, MD (1) · Michael Gelfand, MD, PhD (1) · Sara K Inati, M.D. (1) · Selim Benbadis, MD (1) · Stefan Herrmann, MD (1)
PMID 10227614, PMID 10768306, PMID 16344515, PMID 17283312, PMID 20937567, PMID 37384278, PMID 38499287, PMID 38532258
2023 (1)